118 related articles for article (PubMed ID: 17458297)
1. [Sulfonylureas and glinides].
Hirose T
Nihon Rinsho; 2006 Dec; 64 Suppl 9():646-53. PubMed ID: 17458297
[No Abstract] [Full Text] [Related]
2. [Sulfonylureas and glinides].
Kudo K; Hirose T
Nihon Rinsho; 2011 Jan; 69 Suppl 1():645-53. PubMed ID: 21766676
[No Abstract] [Full Text] [Related]
3. Should diabetic patients treated long-term with sulfonylureas be switched to nateglinide?
Sevinc A
Arch Intern Med; 2003 Jul; 163(14):1741. PubMed ID: 12885691
[No Abstract] [Full Text] [Related]
4. Drugs for type 2 diabetes.
Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
[No Abstract] [Full Text] [Related]
5. Glycaemic control in type 2 diabetes.
Campbell A
Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416
[No Abstract] [Full Text] [Related]
6. Diabetes under control: Understanding oral antidiabetic agents.
Longo R
Am J Nurs; 2010 Feb; 110(2):49-52. PubMed ID: 20107402
[No Abstract] [Full Text] [Related]
7. [Glinides].
Mita T; Watada H
Nihon Rinsho; 2012 May; 70 Suppl 3():608-13. PubMed ID: 22768586
[No Abstract] [Full Text] [Related]
8. [Management guideline for elderly diabetic patients].
Satake S; Iguchi A
Nihon Rinsho; 2002 Sep; 60 Suppl 9():746-51. PubMed ID: 12387079
[No Abstract] [Full Text] [Related]
9. [New glucose regulator. More comfort for the type 2 diabetic patient].
MMW Fortschr Med; 2001 Feb; 143(6):57. PubMed ID: 11247371
[No Abstract] [Full Text] [Related]
10. [Antidiabetic Drugs and the Kidney].
Candido R
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960013
[No Abstract] [Full Text] [Related]
11. Glimepiride and serum adiponectin level in type 2 diabetic subjects: response to Nagasaka et al.
Yoshioka K; Yoshida T; Yoshikawa T
Diabetes Care; 2003 Dec; 26(12):3360-1; author reply 3361. PubMed ID: 14633838
[No Abstract] [Full Text] [Related]
12. [Fasting hyperglycemia and postprandial glucose peaks. Diabetes therapy mustact on 2 sides].
MMW Fortschr Med; 2003 Aug; 145(33-34):59. PubMed ID: 14526583
[No Abstract] [Full Text] [Related]
13. Postprandial hyperglycemia: are all sulfonylureas created equal?
Kapoor JR
Am J Cardiol; 2008 Feb; 101(4):554-5. PubMed ID: 18312779
[No Abstract] [Full Text] [Related]
14. [Glinide(s), sulfonylurea(s)].
Arakawa M; Hirose T
Nihon Rinsho; 2006 Nov; 64(11):2107-12. PubMed ID: 17087304
[TBL] [Abstract][Full Text] [Related]
15. [Prandial glucose regulator and insulin secretagogue; glinide and its combination therapy].
Nakashima E
Nihon Rinsho; 2015 Mar; 73(3):416-23. PubMed ID: 25812367
[TBL] [Abstract][Full Text] [Related]
16. Failure of sulfonylureas in type 2 diabetes.
Yildiz BO; Gürlek A
Horm Metab Res; 1999 Apr; 31(4):293-4. PubMed ID: 10333089
[No Abstract] [Full Text] [Related]
17. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
Charbonnel B
Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
[No Abstract] [Full Text] [Related]
18. [Sulfonylureas].
Kobayashi K; Shimano H
Nihon Rinsho; 2012 May; 70 Suppl 3():602-7. PubMed ID: 22768585
[No Abstract] [Full Text] [Related]
19. [Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Pro].
Nauck MA
Dtsch Med Wochenschr; 2011 Mar; 136(11):546. PubMed ID: 21351041
[No Abstract] [Full Text] [Related]
20. Current oral agents for type 2 diabetes. Many options, but which to choose when?
Ahmann AJ; Riddle MC
Postgrad Med; 2002 May; 111(5):32-4, 37-40, 43-6. PubMed ID: 12040862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
